Skip to main content

and
  1. No Access

    Article

    Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

    For patients with acquired severe aplastic anemia without a matched sibling donor and not responding to immunosuppressive treatment, bone marrow transplantation from a suitable alternative donor is often attem...

    J R Passweg, W S Pérez, M Eapen, B M Camitta, E Gluckman in Bone Marrow Transplantation (2006)

  2. No Access

    Article

    Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

    To determine the role of allogeneic, autologous and syngeneic hemopoietic stem cell transplantation (SCTx) as a treatment for severe autoimmune disease (AID) we performed a literature search employing Medline,...

    W Hinterberger, M Hinterberger-Fischer, A Marmont in Bone Marrow Transplantation (2002)

  3. No Access

    Article

    Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation

    We assessed long-term outcome in 155 patients who had undergone an allogeneic/syngeneic stem cell transplant (SCT) and were in complete remission for more than 2 years after transplant. Probability of late tra...

    N Worel, D Biener, P Kalhs, M Mitterbauer, F Keil in Bone Marrow Transplantation (2002)

  4. No Access

    Article

    Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma

    From 1987 to 1999 35 patients with poor prognosis non-Hodgkin's lymphoma (NHL) underwent allogeneic stem cell transplantation (SCT) at the University Hospitals of Vienna and Graz. Initial biopsy specimens were...

    M Mitterbauer, P Neumeister, P Kalhs, S Brugger, G Fischer, K Dieckmann in Leukemia (2001)

  5. No Access

    Article

    Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD)

    We describe an allogeneic bone marrow (BM) recipient who developed aggressive, metastasizing squamous cell cancer (SCC) of the skin, and discuss possible risk factors in the development of this secondary solid...

    B Gmeinhart, W Hinterberger, HT Greinix, W Rabitsch in Bone Marrow Transplantation (1999)

  6. No Access

    Article

    Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

    Between April 1982 and February 1997 39 patients (24 male, 15 female) with refractory acute leukemia and a median age of 31 years (19–51 years) received allogeneic marrow grafts from an HLA-identical sibling (n =...

    HT Greinix, E Reiter, F Keil, G Fischer, K Lechner in Bone Marrow Transplantation (1998)

  7. No Access

    Article

    Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia

    Between 1982 and 1996, 20 patients (10 male, 10 female) with severe aplastic anemia (SAA) with a median age of 25 years (17–37 years), received grafts from an HLA-identical sibling (n = 17), HLA-identical unrelat...

    E Reiter, F Keil, S Brugger, P Kalhs, W Rabitsch in Bone Marrow Transplantation (1997)

  8. No Access

    Chapter and Conference Paper

    Hämatologie II

    Nach dem 1. oder 2. Rezidiv wird die akute myeloische Leukämie (AML) nahezu aller Patienten resistent gegenüber den bisherigen, als wirksamste Zytostatika Cytarabin und Anthrazykline enthaltenden Therapieschem...

    P. Meusers, H. Heidemann, C. Lunscken, M. Uppenkamp, P. Zou, G. Brittinger in 90. Kongreß (1984)

  9. No Access

    Chapter and Conference Paper

    Hämatologie/Onkologie

    Die intraerythrozytäre Ferritinkonzentration ist zusätzlich zur Serum- bzw. Plasmaferritin-konzentration [9] für die Beurteilung des Eisenhaushalts geeignet [3]. Bei latentem Eisenmangel ist die Ferritinkonzen...

    H. H. Bodemann, A. Rieger, H. Schröter-Urban in Verhandlungen der Deutschen Gesellschaft f… (1983)

  10. No Access

    Chapter and Conference Paper

    Hämatologie/Onkologie

    Kolonienstimulierende Faktoren („Colony Stimulating Factors, CSF“) stimulieren in vitro das Wachstum von myeloisch determinierten Stammzellen („Colony Forming Units, CFUC“). Von den Blutzellen sind es ausschließl...

    W. Hinterberger, P. Bettelheim in Verhandlungen der Deutschen Gesellschaft f… (1982)